| Literature DB >> 33479653 |
M I Osella1, M O Salazar1, M D Gamarra2, D M Moreno3, F Lambertucci4, D E Frances4, R L E Furlan1.
Abstract
A series of simple N-arylbenzenesulfonyl histamine derivatives were prepared and screened against α-glucosidase. Inhibition was in the micromolar range for several N α,N τ-di-arylsulfonyl compounds, with N α,N τ-di-4-trifluorobenzenesulfonyl histamine (IId) being the best inhibitor. Compound IId is a reversible and competitive α-glucosidase inhibitor, and presented good selectivity with respect to other target enzymes, including β-glucosidase and α-amylase, and interesting predicted physicochemical properties. Docking studies have been run to postulate ligand-enzyme interactions to account for the experimental results. In vivo, compound IId produced a similar hypoglycemic effect to acarbose with half of its dose. This journal is © The Royal Society of Chemistry 2020.Entities:
Year: 2020 PMID: 33479653 PMCID: PMC7489258 DOI: 10.1039/c9md00559e
Source DB: PubMed Journal: RSC Med Chem ISSN: 2632-8682